Did you know that IHH has a data team that recently developed and launched our very own AI-powered billing estimation tool?
The in-house solution FeeAdvisor.ai has been progressively deployed in our hospitals in Malaysia – 6 currently with 2 more by the end of the year. By end of 2022, most if not all our 16 hospitals in Malaysia will be using the AI tool. The product will also be pilot tested in Gleneagles Hospital Hong Kong.
Bill estimation is an integral part of our hospitals’ financial counselling process where patients get clarification regarding their medical bills prior to admission.
Dirk Schraven, IHH’s Group Head of Data & Value Driven Outcomes (VDO), said: “Using artificial intelligence, we are able to give our patients greater price transparency, accurate cost estimates, and timely cost updates during an unplanned care situation. This empowers patients to make better informed decisions regarding the various treatment options available. By giving patients and their family members greater peace of mind and enabling them to focus on getting well, we in turn gain their trust.”
By comparison, conventional bill estimation methods are based on statistical calculation of historical hospital bill sizes from past admissions and do not account for dynamically changing factors such as disease aggravation, patient’s medical condition, and medical practices resulting in longer length of stay or unexpected treatments.
While AI has been deployed to estimate bills in our 4 Singapore hospitals since 2018, this new tool is the first to be built and developed by an in-house team.
Allen Tan, AVP of Business Analytics, said: “It was a challenge we set for ourselves. Borrowing the idea of bill estimation, our team developed a minimal viable product in just three months. After a successful pilot phase, we started to deploy the product to hospitals in Malaysia. We couldn’t be happier with the results and feedback so far. Our next focus is on improving the solution to be more responsive to treatment changes so as to provide a better patient experience.”
FeeAdvisor.ai is just one of the in-house developed data products under #IHHMade. The team is working on several other prototypes including Package Value Optimiser, Robo Claims and Social Media Text Analysis - that are developed by IHH, for IHH.
These solutions are all part of IHH’s digital transformation journey to enhance operational efficiencies and to deliver better, easier, faster and more cost-effective healthcare to our patients.
Related Stories
Friends of Fortis Programme Highlights Robotic Knee Replacement Outcomes in Amritsar
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
